# Reevaluation Of Systemic Early Neuromuscular Blockade

> **NCT02509078** · PHASE3 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 1008 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Cisatracurium Besylate

## Key facts

- **NCT ID:** NCT02509078
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-04
- **Primary completion:** 2018-07-03
- **Final completion:** 2019-04-04
- **Target enrollment:** 1008 (ACTUAL)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509078, "Reevaluation Of Systemic Early Neuromuscular Blockade". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02509078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*